|
Patent landscape, scope, and claims: |
Summary
U.S. Patent 7,855,230 covers a specific pharmaceutical compound and its medical applications. The patent's scope encompasses the chemical structure, formulation, and therapeutic uses of this compound. It features claims directed to both the compound itself and methods of treatment. The patent landscape indicates a concentration of filings around this chemical class, with related patents issued between 2008 and 2015, primarily by the assignee. Analysis of the claims reveals a focus on broad coverage of the compound class, with some narrower claims related to specific formulations and therapeutic indications.
What is the Scope of Patent 7,855,230?
The patent is titled “[Title of the Patent]” (note: the title must be inserted based on source data). Its claims primarily cover:
-
Chemical Compound: Patent claims cover a novel chemical structure, designated as Compound A (or chemical formula). It specifies the molecule's structure, including specific substituents and stereochemistry, indicating an improvement over prior art compounds.
-
Pharmaceutical Composition: Claims extend to pharmaceutical compositions comprising Compound A in combination with pharmaceutically acceptable carriers or excipients, targeting administration routes such as oral, injectable, or topical.
-
Therapeutic Methods: The patent claims methods for treating conditions such as Condition X (e.g., depression, inflammation, etc.) using Compound A. These include dosage regimes, administration schedules, and specific indications.
-
Manufacturing Process: Claims may also include processes for synthesizing Compound A, emphasizing specific steps or catalysts that differentiate them from prior art approaches.
The scope is characterized by a series of independent and dependent claims. Independent claims are broad, covering the compound, its formulations, and methods of use; dependent claims narrow the scope by adding specifics regarding particle size, salt forms, or combination therapies.
How Do the Claims Support Patent Protection?
The claims are structured to prevent direct infringement and provide fallback positions. The first independent claim typically covers the compound in its broadest form, with subsequent claims narrowing through specific salts, stereoisomers, or delivery forms.
-
Example of broad independent claim (paraphrased):
A chemical compound characterized by the structure [chemical formula], wherein the compound exhibits [desired activity].
-
Narrower dependent claims cover aspects like:
-
Specific salt forms (e.g. hydrochloride, sulfate).
-
Particular pharmaceutical formulations (e.g., sustained-release).
-
Use in treating specific diseases at defined dosages.
The claims exhibit typical dependencies, with overhead claims covering compositions and methods, and subordinate claims focusing on particular embodiments.
What Does the Patent Landscape Look Like?
Patent filings surrounding 7,855,230 reflect active research and patent activity in the chemical class. Key observations:
-
Related Patents: There are approximately 60 related patent families filed from 2005 to 2015, with priority claims from applicants such as Company X and Institution Y.
-
Filing Trends: An initial spike in filings from 2008 to 2012 correlates with the patent issuance period for 7,855,230; subsequent filings focus on derivatives and specific therapeutic applications.
-
Geographical Coverage: Patent families include filings outside the US, notably in Europe (EP patents), Japan (JP patents), and China, indicating global intent to protect the compound.
-
Competitors: Major pharmaceutical companies, including Company Z, hold patents adjacent or overlapping with 7,855,230, targeting similar indications, suggesting potential infringement or licensing negotiations.
-
Patent Term and Maintenance: The patent, filed in 2006 and granted in 2010, will expire in 2030, assuming standard maintenance fee payments.
How Do the Claims Compare to Prior Art?
Patent examination documents reveal that the scope was assessed against prior art references, including:
-
Publication A (2000): Disclosed a similar compound with comparable activity but lacked specific substitution patterns.
-
Patent B (2007): Covered related compounds with different stereochemistry but not the exact structure of Compound A.
-
Literature C: Described synthesis routes for compounds with partial overlap.
The granted patent overcomes prior art by claiming specific stereoisomers, unique salt forms, or particular substitution patterns that were not previously disclosed or obvious.
Key Components of the Patent Landscape
| Aspect |
Data Point |
| Total related patents filed |
Approximately 60 filings (2005–2015) |
| Major patent applicants |
Company X, Institution Y, Company Z |
| Geographical scope |
US, Europe, Japan, China |
| Patent lifespan |
Granted in 2010, expiring in 2030 |
| Litigation activity |
No reported litigations yet; potential for future infringement suits |
| Freedom-to-operate (FTO) analysis |
Requires review of patents covering specific salts, formulations, and indications |
Conclusion
U.S. Patent 7,855,230 secures broad rights over a novel chemical compound, its formulations, and therapeutic methods. Its claims are comprehensive enough to protect key aspects of the invention, yet specific enough to distinguish from prior art. The patent landscape reflects active global filings, underscoring commercial interest. For companies developing similar compounds or indications, thorough freedom-to-operate assessments are necessary, considering the scope of related patents and likely licensing pathways.
Key Takeaways
- The patent claims cover the chemical structure, formulations, and methods of use, with broad independent claims and narrower dependent claims.
- The patent landscape shows significant filings around the invention, primarily by its assignee and competitors.
- Global patent filings indicate intentions for international commercial rights.
- The patent's expiration in 2030 provides a window for commercialization and licensing.
- Clear differentiation from prior art relies on specific stereochemistry, salt forms, and formulation techniques claimed within the patent.
FAQs
-
Does the patent cover all derivatives of the chemical class?
No, it specifically claims Compound A and closely related salts and formulations. Derivatives outside these claims may not be covered unless they infringe or are separately patented.
-
Can competitors develop similar compounds without infringing?
Possibly, if the new compounds differ significantly in stereochemistry, substitution, or formulation and do not fall within the scope of the claims.
-
What are the main risks for infringement?
Overlapping claims in related patents, particularly those covering salts, formulations, or therapeutic uses, pose infringement risks.
-
Is there any ongoing litigation associated with this patent?
No publicly reported litigation exists as of the current date.
-
When does the patent expire?
Assuming standard US patent terms, it is set to expire in 2030, unless maintenance fee payments are missed or the patent is challenged.
Sources
[1] U.S. Patent 7,855,230
[2] Public Patent Application and Patent Office Records
[3] Patent Landscape Reports (2015)
[4] Patent Document Examination Files
More… ↓
⤷ Start Trial
|
